FOLD

FOLD Total Costs & Expenses

$601.42MTTM · USD

Period ending:

FOLD FY Total Costs & ExpensesUSD
FOLD FY Total Costs & Expenses2003-12-31: $6.60M2004-12-31: -$8.81M2005-12-31: $20.83M2006-12-31: $46.86M2007-12-31: $47.59M2008-12-31: $58.92M2009-12-31: $70.19M2010-12-31: $56.76M2011-12-31: $72.32M2012-12-31: $71.34M2013-12-31: $62.56M2014-12-31: $69.89M2015-12-31: $126.05M2016-12-31: $180.02M2017-12-31: $247.81M2018-12-31: $416.72M2019-12-31: $486.27M2020-12-31: $507.88M2021-12-31: $511.95M2022-12-31: $541.35M2023-12-31: $476.57M2024-12-31: $503.42M2025-12-31: $599.72M$599.72M-$8.81M
2003-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

FOLD total costs & expenses history

Total of all costs and expenses. The available annual fiscal periods series contains 23 observations from Dec 31, 2003 to Dec 31, 2025.

Amicus Therapeutics Inc Total Costs & Expenses — Annual fiscal periods (USD)
Period endingTotal Costs & Expenses (USD)
599,719,000
503,419,000
476,567,000
541,353,000
511,948,000
507,884,000
486,274,000
416,722,000
247,810,000
180,019,000
126,045,000
69,888,000
62,556,000
71,342,000
72,321,000
56,760,000
70,186,000
58,923,000
47,589,000
46,859,273
20,831,355
-8,807,102
6,600,000

Compare total costs & expenses

All FOLD financial metrics · FOLD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.